OTCMKTS:MKKGY

MERCK Kommanditgesellschaft auf Aktien Stock Forecast, Price & News

$34.83
-0.48 (-1.36 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$34.83
Now: $34.83
$35.11
50-Day Range
$30.68
MA: $33.21
$35.31
52-Week Range
$20.06
Now: $34.83
$36.50
Volume22,375 shs
Average Volume69,736 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer or multiple sclerosis, infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as carcinoma of the head and neck; prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for the research and applied laboratory applications, as well as for formulating, purifying, manufacturing, and quality-assuring drug therapies of chemical and biological origin; and specialty chemicals, such as liquid crystals and OLED materials for use in displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Intrexon Corporation and Avillion LLP; collaboration with F-star Delta Ltd.; an agreement IAVI and Serum Institute of India Pvt. Ltd. to develop SARS-CoV-2 neutralizing monoclonal antibodies; and collaboration with Iktos for new drug design. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
MERCK Kommanditgesellschaft auf Aktien logo

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MKKGY
CUSIPN/A
CIKN/A
Phone+49-6151-720
Employees58,127
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

Merck KGaA to boost lipid supply to vaccine maker BioNTech
February 5, 2021 |  finance.yahoo.com
Merck is about to announce earnings — here's what Wall Street expects
October 27, 2020 |  markets.businessinsider.com
Why Precigen Stock Is Skyrocketing Today
October 16, 2020 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

0.46 out of 5 stars

Medical Sector

1669th out of 2,016 stocks

Drug Manufacturers - Specialty & Generic Industry

54th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$34.83
-0.48 (-1.36 %)
(As of 04/12/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MKKGY News and Ratings via Email

Sign-up to receive the latest news and ratings for MKKGY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) Frequently Asked Questions

Is MERCK Kommanditgesellschaft auf Aktien a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MERCK Kommanditgesellschaft auf Aktien in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MERCK Kommanditgesellschaft auf Aktien stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MKKGY, but not buy additional shares or sell existing shares.
View analyst ratings for MERCK Kommanditgesellschaft auf Aktien
or view top-rated stocks.

What stocks does MarketBeat like better than MERCK Kommanditgesellschaft auf Aktien?

Wall Street analysts have given MERCK Kommanditgesellschaft auf Aktien a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MERCK Kommanditgesellschaft auf Aktien wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 10,300 shares, an increase of 56.1% from the March 15th total of 6,600 shares. Based on an average trading volume of 51,200 shares, the short-interest ratio is currently 0.2 days.
View MERCK Kommanditgesellschaft auf Aktien's Short Interest
.

How has MERCK Kommanditgesellschaft auf Aktien's stock price been impacted by COVID-19?

MERCK Kommanditgesellschaft auf Aktien's stock was trading at $21.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MKKGY shares have increased by 58.6% and is now trading at $34.83.
View which stocks have been most impacted by COVID-19
.

Who are MERCK Kommanditgesellschaft auf Aktien's key executives?

MERCK Kommanditgesellschaft auf Aktien's management team includes the following people:
  • Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 64)
  • Ms. Belen Garijo Lopez M.D., Vice Chairman of the Exec. Board & Deputy CEO (Age 61)
  • Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 53)
  • Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 56)
  • Mr. Peter Guenter, CEO of Healthcare Bus. & Member of Exec. Board (Age 59)
  • Mr. Gerhard Schmitz, Head of Global Accounting (Age 58)
  • Mr. Dirk Toepfer, Chief Information Officer
  • Mr. Constantin Fest, Head of Investor Relations (Age 44)
  • Dr. Friederike Rotsch, Group Gen. Counsel and Head of Group Legal & Compliance (Age 49)
  • Ms. Barbara Weiland, Chief Compliance Officer (Age 47)

Who are some of MERCK Kommanditgesellschaft auf Aktien's key competitors?

What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?

MERCK Kommanditgesellschaft auf Aktien trades on the OTCMKTS under the ticker symbol "MKKGY."

How do I buy shares of MERCK Kommanditgesellschaft auf Aktien?

Shares of MKKGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MERCK Kommanditgesellschaft auf Aktien's stock price today?

One share of MKKGY stock can currently be purchased for approximately $34.83.

How many employees does MERCK Kommanditgesellschaft auf Aktien have?

MERCK Kommanditgesellschaft auf Aktien employs 58,127 workers across the globe.

What is MERCK Kommanditgesellschaft auf Aktien's official website?

The official website for MERCK Kommanditgesellschaft auf Aktien is www.merckgroup.com.

Where are MERCK Kommanditgesellschaft auf Aktien's headquarters?

MERCK Kommanditgesellschaft auf Aktien is headquartered at Frankfurter Strasse 250, DARMSTADT, 64293, Germany.

How can I contact MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien's mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The company can be reached via phone at +49-6151-720.


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.